Form 13-F position report

ELEVANCE HEALTH INC.

Reported by Washington Trust Bank

ELV CUSIP 036752103 Manager CIK 0000861787

Reported 30,153 shares, down 396 (1.3%) from the prior quarter.

Reported value 3.1%; share count -1.3% vs. the prior quarter.

Reduced
% of reported 13F value 1.62% This manager · Q2 2024
Shares 30,153 Quarter-end amount reported
Reported value $16,338,704 Fair value at quarter end
Consecutive quarters held 38 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 15338000
2022-03-31 15454000
2022-06-30 14278000
2022-09-30 12956000
2022-12-31 14147000
2023-03-31 14456427
2023-06-30 14008908
2023-09-30 13606875
2023-12-31 14830090
2024-03-31 15840879
2024-06-30 16338704
2024-09-30 15260440
2024-12-31 10872221
2025-03-31 13456793
2025-06-30 12643922
2025-09-30 11574481
2025-12-31 12195635
2026-03-31 760858
2026-06-30 601365
2026-09-30 531129

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ELEVANCE HEALTH INC. held by Washington Trust Bank.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 1,366 -189 (-12.2%) 0.04% $531,129 2026-11-03
Q2 2026 Reduced 1,555 -1,044 (-40.2%) 0.04% $601,365 2026-08-05
Q1 2026 Reduced 2,599 -32,191 (-92.5%) 0.06% $760,858 2026-05-07
Q4 2025 Reduced 34,790 -1,031 (-2.9%) 0.85% $12,195,635 2026-02-04
Q3 2025 Added 35,821 +3,314 (10.2%) 0.85% $11,574,481 2025-10-24
Q2 2025 Added 32,507 +1,569 (5.1%) 1.06% $12,643,922 2025-08-06
Q1 2025 Added 30,938 +1,466 (5.0%) 1.35% $13,456,793 2025-04-30
Q4 2024 Added 29,472 +125 (0.4%) 1.04% $10,872,221 2025-02-11
Q3 2024 Reduced 29,347 -806 (-2.7%) 1.46% $15,260,440 2024-10-31
Q2 2024 Reduced 30,153 -396 (-1.3%) 1.62% $16,338,704 2024-07-29
Q1 2024 Reduced 30,549 -900 (-2.9%) 1.51% $15,840,879 2024-05-14
Q4 2023 Added 31,449 +199 (0.6%) 1.31% $14,830,090 2024-02-14
Q3 2023 Reduced 31,250 -281 (-0.9%) 1.42% $13,606,875 2023-11-06
Q2 2023 Added 31,531 +91 (0.3%) 1.43% $14,008,908 2023-08-10
Q1 2023 Added 31,440 +3,861 (14.0%) 1.55% $14,456,427 2023-05-15
Q4 2022 Reduced 27,579 -943 (-3.3%) 1.6% $14,147,000 2023-02-06
Q3 2022 Reduced 28,522 -1,063 (-3.6%) 1.65% $12,956,000 2022-11-16
Q2 2022 Reduced 29,585 -1,875 (-6.0%) 1.83% $14,278,000 2022-08-04
Q1 2022 Reduced 31,460 -1,630 (-4.9%) 1.79% $15,454,000 2022-05-13
Q4 2021 Reduced 33,090 -58 (-0.2%) 1.48% $15,338,000 2022-02-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1806 managers reported ELEVANCE HEALTH INC. for Q2 2024.

Managers reporting ELEVANCE HEALTH INC. in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 21,206,925 -24,784 0.22% $11,491,184,380 39 qtrs
BlackRock Inc Reduced 20,704,715 -215,981 0.25% $11,219,056,885 39 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 11,646,526 -73,734 0.76% $6,310,788,000 39 qtrs
STATE STREET CORPORATION Added 10,558,289 +78,528 0.25% $5,721,114,478 35 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 4,762,250 +67,365 0.23% $2,573,092,803 39 qtrs
FMR LLC Added 4,746,833 +693,525 0.16% $2,572,119,300 39 qtrs
Sanders Capital LLC Added 4,564,453 +57,256 3.79% $2,473,294,503 39 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 4,174,680 -324,949 0.4% $2,262,092,107 39 qtrs
AMERIPRISE FINANCIAL INC Added 3,791,793 +190,118 0.56% $2,054,640,544 39 qtrs
Capital International Investors Added 3,732,975 +234,464 0.42% $2,022,411,485 22 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
July 29, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
29,480
Shared
0
None
673

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.